Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 2.8/5
Genomma Lab Internacional Sab (LABB MM)
Watchlist
Contact IR
12
Analysis
Health Care
•
Mexico
Genomma Lab Internacional SAB de CV develops, markets, sells and distributes over-the-counter drugs and personal care products.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Genomma Lab Internacional Sab
•
18 Mar 2025 14:00
•
Syndicated
Actinver Research - Genomma Lab 4Q24: Strong finish and positive outlook
Revenues of P$4.7bn grew 32.4% YoY, supported by healthy growth across all regions and FX tailwinds (e.g., U.S. sales grew 1.8% in local currency,...
Actinver
Follow
217 Views
Share
bullish
•
Genomma Lab Internacional Sab
•
27 Feb 2025 04:00
•
Syndicated
Actinver Research - Genomma Lab 4Q24: Healthy finish of the year (Quick View)
Revenues of P$4.7bn grew 32.4% YoY, supported by healthy growth across all regions. Sales in Mexico were in line with our estimates, while in...
Actinver
Follow
252 Views
Share
bullish
•
Genomma Lab Internacional Sab
•
10 Dec 2024 15:00
•
Syndicated
Actinver Research - Genomma Lab: Reaching Healthier Valuation Levels (Company Update)
After a stunning YTD performance (up 90.68% as of 12/9/24 vs MEXBOL 9.05% down), we continue to see solid upside ahead. Market conditions for most...
Actinver
Follow
283 Views
Share
bullish
•
Genomma Lab Internacional Sab
•
24 Oct 2024 15:00
•
Syndicated
Actinver Research - Genomma Lab 3Q24: Strong across the board (Quick View)
Revenues of P$5.1bn grew 15.9% YoY and were 6.8% above our estimates, supported by healthy growth across all regions. For a second consecutive...
Actinver
Follow
202 Views
Share
bullish
•
Macroeconomics
•
12 May 2025 17:02
•
Syndicated
Actinver Research - Consumer Post 1Q25 Update
Soft consumer environment, with weaker conditions at the beginning of the year vs the company’s expectations; a warmer season didn’t help either.
Actinver
Follow
188 Views
Share
1
2
3
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x